NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases ...

“The first quarter of 2025 was a period of focused execution and acceleration at Metsera,” said Whit Bernard, Chief Executive Officer of Metsera. “We remain on track to deliver on all of our ...

"The first quarter of 2025 was a period of focused execution and acceleration at Metsera,” said Whit Bernard, Chief Executive Officer of Metsera. "We remain on track to deliver on all of our committed ...

"The first quarter of 2025 was a period of focused execution and acceleration at Metsera," said Whit Bernard, Chief Executive Officer of Metsera. "We remain on track to deliver on all of our ...

Metsera, Inc., a clinical-stage biopharmaceutical company focused on treating obesity and metabolic diseases, announced its first quarter 2025 financial results, highlighting significant progress ...

More info. Google doesn’t update its logos very often, but at the 10-year mark of a design, we have seen them switch things up. For example, Google Play saw a logo refresh when it reached 10 ...

Metsera is leaving no fundraising stone unturned as it races to grab a slice of the fast-growing market for obesity drugs. Just nine months after emerging from stealth with a $290 million Series A ...

If any further evidence were needed for the insatiable investor appetite for companies with obesity assets, look no further than New York start-up Metsera. After emerging from stealth with a $290 ...

The deadline to fly without a REAL ID has come and gone in most states. If you're planning on flying or entering a federal building, you'll need a driver's license or state identification card ...